Cardiorenal protective effect of the oral uremic toxin absorbent AST-120 in chronic heart disease patients with moderate CKD.
about
The role of AST-120 and protein-bound uremic toxins in irritable bowel syndrome: a therapeutic perspectiveChronic kidney disease-induced cardiac fibrosis is ameliorated by reducing circulating levels of a non-dialysable uremic toxin, indoxyl sulfate.The uremic toxin adsorbent AST-120 abrogates cardiorenal injury following myocardial infarction.Effect of an Oral Adsorbent, AST-120, on Dialysis Initiation and Survival in Patients with Chronic Kidney Disease.Untargeted plasma and tissue metabolomics in rats with chronic kidney disease given AST-120.Role of Indoxyl Sulfate as a Predisposing Factor for Atrial Fibrillation in Renal Dysfunction.Role of anuria in the relationship between indoxyl sulfate and anemia in peritoneal dialysis patients.Protein-bound uremic toxins: new culprits of cardiovascular events in chronic kidney disease patients.Indoxyl Sulfate: A Novel Cardiovascular Risk Factor in Chronic Kidney Disease.Oral activated charcoal adsorbent (AST-120) ameliorates chronic kidney disease-induced intestinal epithelial barrier disruptionGut Microbiota and Cardiovascular Uremic Toxicities
P2860
Q26795563-9B8D03E8-C10E-4E0B-BB31-C8123BBB6F63Q31076633-96887C70-C7F8-43CF-977B-E354D2D3069EQ35071066-F75F9509-0D40-4D71-BA95-AE6913F3CBA1Q35687482-880BDF55-7D1A-4DF1-A6C8-5D554F29686BQ36638243-3C13B28F-D571-44AA-99E9-C580CA1B3CA1Q36836055-2FE1AC00-7470-480B-BB45-E50E1E183E1DQ37468522-4ADBE578-6F7E-42C1-8AD8-930E5A9D21ECQ38190366-95F746C6-A07F-456A-A3BA-967ED820CC8CQ39125093-CB726863-0B90-41A3-860D-996EDE64CD58Q42042998-8E43E497-5A3A-46FE-958B-A1090658B2EBQ57176511-19B8CD71-6455-4FEA-BA0F-FF51A8E5C1FA
P2860
Cardiorenal protective effect of the oral uremic toxin absorbent AST-120 in chronic heart disease patients with moderate CKD.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Cardiorenal protective effect ...... se patients with moderate CKD.
@en
type
label
Cardiorenal protective effect ...... se patients with moderate CKD.
@en
prefLabel
Cardiorenal protective effect ...... se patients with moderate CKD.
@en
P1476
Cardiorenal protective effect ...... ase patients with moderate CKD
@en
P2093
Hiroshi Shibahara
Nami Shibahara
P304
P577
2010-09-01T00:00:00Z